Trial of Autologous Marrow derived Stem Cell Ovarian Transplantation (TAMSCOT) in young infertile women with diminished ovarian reserve for ovarian rejuvenation - HOPE still persists

被引：0

|

作者：

Singh, N. ^{[1
]}

Dogra, Y. ^{[1
]}

Mohanty, S. ^{[2
]}

Seth, T. ^{[3
]}

机构：

[1] All India Inst Med Sci, Dept Obstet & Gynaecol, New Delhi, India

[2] All India Inst Med Sci, Stem Cell Facil, New Delhi, India

[3] All India Inst Med Sci, Dept Haematol, New Delhi, India

来源：

HUMAN REPRODUCTION | 2021年 / 36卷

关键词：

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-796

引用

收藏

页码：499 / 500

页数：2

相关论文

共 32 条

[31] Anti-Muellerian hormone (AMH) as only possible marker in the assessment of ovarian function and reserve after hematopoietic stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal replacement therapy
Wedrychowicz, A.
Wojtys, J.
Starzyk, J.
BONE MARROW TRANSPLANTATION, 2017, 52 (02) : 313 - 316
[32] Anti-Muellerian hormone (AMH) as only possible marker in the assessment of ovarian function and reserve after hematopoietic stem cell transplantation (HSCT) in prepubertal girls, young females with composed hypogonadism and females receiving hormonal replacement therapy
A Wędrychowicz
J Wojtyś
J Starzyk
Bone Marrow Transplantation, 2017, 52 : 313 - 316

← 1 2 3 4 →